Starbucks union: Company threatens that unionizing could jeopardize gender-affirming health care

Starbucks union: Company threatens that unionizing could jeopardize gender-affirming health care


A protester waves a sign near the Country Club Plaza Starbucks store where dozens of Starbucks employees and union supporters protested alleged anti-union tactics by the company Thursday, March 3, 2022.

Jill Toyoshiba | Tribune News Service | Getty Images

Starbucks is telling its baristas that unionizing could jeopardize the gender-affirming health care coverage for transgender employees that the company offers, according to a complaint filed with the federal labor board.

The complaint comes after more than 100 of the coffee chain’s 9,000 U.S. cafes have voted to unionize under Workers United in the last seven months. Under interim CEO Howard Schultz, Starbucks has been trying to counter the union push by emphasizing the potential shortcomings of collective bargaining, such as federal labor laws that prohibit the company from unilaterally hiking wages across unionized cafes without contract negotiations.

The union’s latest complaint against Starbucks, first reported by Bloomberg, was filed Monday. A transgender employee at an Oklahoma City location told the publication that she believed her manager used a “veiled threat” in a conversation. The manager reportedly told the employee that her benefits could improve, stay the same or worsen if the store unionized and referred specifically to her use of the trans health-care benefits.

Starbucks spokesman Reggie Borges told CNBC that the claim is false.

The company’s health insurance has covered gender reassignment surgery since 2012 and a wider array of gender-affirming procedures, like hair transplants or breast reduction, since 2018. Last month, the coffee chain announced it would cover travel expenses for gender-affirming surgeries as state lawmakers target transgender rights.

As of mid-March, more than 150 anti-trans bills had been introduced in state legislatures seeking to limit access to health care, sports, bathrooms and education, according to NBC News. Oklahoma, for example, has passed three anti-trans laws this year.

Starbucks often touts its long history of supporting LGBTQ+ workers and the broader community, particularly during Pride Month in June. The company notes its decades-old policies including health care coverage for same-sex domestic partnerships and employees with terminal illnesses, inspired by Starbucks worker who died of complications from AIDs.



Source

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Business

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus. The agency said the risk […]

Read More
These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More